shivering. Abnormal involuntary movements
Conditions
Interventions
Intervention 1: Intervention group: Ketamine 0.2mg/kg /iv after placing patient on surgical position. Intervention 2: Control group: placebo is injecting in equal volume of Ketamine intravenously afte
Prevention
Placebo
Intervention group: Ketamine 0.2mg/kg /iv after placing patient on surgical position
Control group: placebo is injecting in equal volume of Ketamine intravenously after placed patient on surgical position.
Sponsors
Paramedical faculty, Qazvin University of Medical sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients with orthopedic, urology or general surgeries. Exclusion criteria: patients with anesthesia risk above 3.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Shivering. Timepoint: every 5 min. Method of measurement: Observational Grade. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHabibollah Mehdipoor
Qazvin University of Medical Sciences
Outcome results
None listed